This report provides a comprehensive analysis of the global Tongfengshu Tablets market, focusing on its application in treating gout and hyperuricemia. It examines market dynamics, including growth drivers and emerging opportunities across key regions such as China, the United States, and Europe. The study offers detailed segmentation by tablet type and application, while evaluating the competitive landscape of leading pharmaceutical manufacturers. Ultimately, the research delivers a nuanced forecast of market trajectories and strategic developments through 2032.

Executive Overview

Market Summary

The global Tongfengshu Tablets market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate during the forecast period.

Product Description

Tongfengshu tablets are a traditional Chinese medicine preparation used to treat gout and hyperuricemia. Their therapeutic functions include:

• Lowering the level of uric acid in the blood.
• Relieving joint pain and inflammation caused by gout.
• Improving related symptoms by clearing away heat and dampness.
• Promoting blood circulation and removing blood stasis.

Regional Market Analysis

Global Outlook

The report provides a comprehensive analysis of projected Tongfengshu Tablets sales from 2026 through 2032, reviewing total world sales in 2025 and providing detailed breakdowns by region and market sector.

Regional Growth Projections

• United States: The market is estimated to increase steadily from 2025 through 2032.
• China: The market is estimated to increase steadily from 2025 through 2032.
• Europe: The market is estimated to increase steadily from 2025 through 2032.

Market Segmentation

By Type

• Each Tablet Weighs 0.35g
• Each Tablet Weighs 0.33g
• Other

By Application

• Hospital
• Clinic
• Other

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Market Dynamics

This report highlights key trends related to product segmentation, company formation, revenue, and market share, as well as the latest developments and M&A activity. It also analyzes the strategies of leading global companies, focusing on:

• Tongfengshu Tablets portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolio, and market penetration:

• Jilin Yimintang Pharmaceutical Co., Ltd.
• Compu Pharmaceutical Co., Ltd.
• Shenyang Oasis Pharmaceutical Co., Ltd.
• Hubei Green Gold Pharmaceutical Co., Ltd.
• Guizhou Liangji Pharmaceutical Co., Ltd.
• Qinhuangdao Daen Pharmaceutical Co., Ltd.
• Shaanxi Panlong Pharmaceutical Group Co., Ltd.
• Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd.
• Shanxi Renyuantang Pharmaceutical Co., Ltd.

Market Concentration: In 2025, the global two largest companies held a significant portion of the total market share.

Research Methodology & Scope

Report Methodology

This Insight Report evaluates key market trends, drivers, and affecting factors shaping the global outlook. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the global Tongfengshu Tablets industry.

Key Questions Addressed

• What is the 10-year outlook for the global Tongfengshu Tablets market?
• What factors are driving Tongfengshu Tablets market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Tongfengshu Tablets market opportunities vary by end market size?
• How does Tongfengshu Tablets break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Tongfengshu Tablets Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Tongfengshu Tablets by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Tongfengshu Tablets by Country/Region, 2021, 2025 & 2032

  • 2.2 Tongfengshu Tablets Segment by Type

    • 2.2.1 Each Tablet Weighs 0.35g

    • 2.2.2 Each Tablet Weighs 0.33g

    • 2.2.3 Other

    • 2.2.4 Tongfengshu Tablets Sales by Type

      • 2.2.4.1 Global Tongfengshu Tablets Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Tongfengshu Tablets Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Tongfengshu Tablets Sale Price by Type (2021-2026)

  • 2.3 Tongfengshu Tablets Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Other

    • 2.3.4 Tongfengshu Tablets Sales by Application

      • 2.3.4.1 Global Tongfengshu Tablets Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Tongfengshu Tablets Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Tongfengshu Tablets Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Tongfengshu Tablets Breakdown Data by Company

    • 3.1.1 Global Tongfengshu Tablets Annual Sales by Company (2021-2026)

    • 3.1.2 Global Tongfengshu Tablets Sales Market Share by Company (2021-2026)

  • 3.2 Global Tongfengshu Tablets Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Tongfengshu Tablets Revenue by Company (2021-2026)

    • 3.2.2 Global Tongfengshu Tablets Revenue Market Share by Company (2021-2026)

  • 3.3 Global Tongfengshu Tablets Sale Price by Company

  • 3.4 Key Manufacturers Tongfengshu Tablets Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Tongfengshu Tablets Product Location Distribution

    • 3.4.2 Players Tongfengshu Tablets Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Tongfengshu Tablets by Geographic Region

  • 4.1 World Historic Tongfengshu Tablets Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Tongfengshu Tablets Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Tongfengshu Tablets Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Tongfengshu Tablets Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Tongfengshu Tablets Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Tongfengshu Tablets Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Tongfengshu Tablets Sales Growth

  • 4.4 APAC Tongfengshu Tablets Sales Growth

  • 4.5 Europe Tongfengshu Tablets Sales Growth

  • 4.6 Middle East & Africa Tongfengshu Tablets Sales Growth

• 5 Americas

  • 5.1 Americas Tongfengshu Tablets Sales by Country

    • 5.1.1 Americas Tongfengshu Tablets Sales by Country (2021-2026)

    • 5.1.2 Americas Tongfengshu Tablets Revenue by Country (2021-2026)

  • 5.2 Americas Tongfengshu Tablets Sales by Type (2021-2026)

  • 5.3 Americas Tongfengshu Tablets Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Tongfengshu Tablets Sales by Region

    • 6.1.1 APAC Tongfengshu Tablets Sales by Region (2021-2026)

    • 6.1.2 APAC Tongfengshu Tablets Revenue by Region (2021-2026)

  • 6.2 APAC Tongfengshu Tablets Sales by Type (2021-2026)

  • 6.3 APAC Tongfengshu Tablets Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Tongfengshu Tablets by Country

    • 7.1.1 Europe Tongfengshu Tablets Sales by Country (2021-2026)

    • 7.1.2 Europe Tongfengshu Tablets Revenue by Country (2021-2026)

  • 7.2 Europe Tongfengshu Tablets Sales by Type (2021-2026)

  • 7.3 Europe Tongfengshu Tablets Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Tongfengshu Tablets by Country

    • 8.1.1 Middle East & Africa Tongfengshu Tablets Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Tongfengshu Tablets Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Tongfengshu Tablets Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Tongfengshu Tablets Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Tongfengshu Tablets

  • 10.3 Manufacturing Process Analysis of Tongfengshu Tablets

  • 10.4 Industry Chain Structure of Tongfengshu Tablets

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Tongfengshu Tablets Distributors

  • 11.3 Tongfengshu Tablets Customer

• 12 World Forecast Review for Tongfengshu Tablets by Geographic Region

  • 12.1 Global Tongfengshu Tablets Market Size Forecast by Region

    • 12.1.1 Global Tongfengshu Tablets Forecast by Region (2027-2032)

    • 12.1.2 Global Tongfengshu Tablets Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Tongfengshu Tablets Forecast by Type (2027-2032)

  • 12.7 Global Tongfengshu Tablets Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Jilin Yimintang Pharmaceutical Co., Ltd

    • 13.1.1 Jilin Yimintang Pharmaceutical Co., Ltd. Company Information

    • 13.1.2 Jilin Yimintang Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.1.3 Jilin Yimintang Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Jilin Yimintang Pharmaceutical Co., Ltd. Main Business Overview

    • 13.1.5 Jilin Yimintang Pharmaceutical Co., Ltd. Latest Developments

  • 13.2 Compu Pharmaceutical Co., Ltd

    • 13.2.1 Compu Pharmaceutical Co., Ltd. Company Information

    • 13.2.2 Compu Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.2.3 Compu Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Compu Pharmaceutical Co., Ltd. Main Business Overview

    • 13.2.5 Compu Pharmaceutical Co., Ltd. Latest Developments

  • 13.3 Shenyang Oasis Pharmaceutical Co., Ltd

    • 13.3.1 Shenyang Oasis Pharmaceutical Co., Ltd. Company Information

    • 13.3.2 Shenyang Oasis Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.3.3 Shenyang Oasis Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Shenyang Oasis Pharmaceutical Co., Ltd. Main Business Overview

    • 13.3.5 Shenyang Oasis Pharmaceutical Co., Ltd. Latest Developments

  • 13.4 Hubei Green Gold Pharmaceutical Co., Ltd

    • 13.4.1 Hubei Green Gold Pharmaceutical Co., Ltd. Company Information

    • 13.4.2 Hubei Green Gold Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.4.3 Hubei Green Gold Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Hubei Green Gold Pharmaceutical Co., Ltd. Main Business Overview

    • 13.4.5 Hubei Green Gold Pharmaceutical Co., Ltd. Latest Developments

  • 13.5 Guizhou Liangji Pharmaceutical Co., Ltd

    • 13.5.1 Guizhou Liangji Pharmaceutical Co., Ltd. Company Information

    • 13.5.2 Guizhou Liangji Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.5.3 Guizhou Liangji Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Guizhou Liangji Pharmaceutical Co., Ltd. Main Business Overview

    • 13.5.5 Guizhou Liangji Pharmaceutical Co., Ltd. Latest Developments

  • 13.6 Qinhuangdao Daen Pharmaceutical Co., Ltd

    • 13.6.1 Qinhuangdao Daen Pharmaceutical Co., Ltd. Company Information

    • 13.6.2 Qinhuangdao Daen Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.6.3 Qinhuangdao Daen Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Qinhuangdao Daen Pharmaceutical Co., Ltd. Main Business Overview

    • 13.6.5 Qinhuangdao Daen Pharmaceutical Co., Ltd. Latest Developments

  • 13.7 Shaanxi Panlong Pharmaceutical Group Co., Ltd

    • 13.7.1 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information

    • 13.7.2 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.7.3 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Main Business Overview

    • 13.7.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Latest Developments

  • 13.8 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd

    • 13.8.1 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Company Information

    • 13.8.2 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.8.3 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Main Business Overview

    • 13.8.5 Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Latest Developments

  • 13.9 Shanxi Renyuantang Pharmaceutical Co., Ltd

    • 13.9.1 Shanxi Renyuantang Pharmaceutical Co., Ltd. Company Information

    • 13.9.2 Shanxi Renyuantang Pharmaceutical Co., Ltd. Tongfengshu Tablets Product Portfolios and Specifications

    • 13.9.3 Shanxi Renyuantang Pharmaceutical Co., Ltd. Tongfengshu Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Shanxi Renyuantang Pharmaceutical Co., Ltd. Main Business Overview

    • 13.9.5 Shanxi Renyuantang Pharmaceutical Co., Ltd. Latest Developments

• 14 Research Findings and Conclusion